MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
WOCKPHARMA has completed a long term correction cycle and now could be a good buy with targets above 2,000 in the long term. The invalidation for this analysis remains at 135.20 (marked level).
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.
#CIPLA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
48 PER broken the 14 year trend lchannel also the lower sloping 3 year ( red Channel)
Pfizer may provide a great risk to reward setup. Multi factor trade setup on pfizer likely sees a technical bounce. Keep in mind markets are weak.
going heavy at the pullback for now just a small amount to feel the progress NEURO is GOLDEN
ELOX with its 1.79M float and volume coming in to turn it about 1 time today unless the volume kicks in....Which is still enough to make this move. Good push down to start the day got in at $3.50 Probably if things stay the way they are now then it could go for !.00 from here. Looking for spikes to volume to catch fomo. As I am typing this volume is dragging...
Sanofi - 30d expiry - We look to Buy a break of 88.01 (stop at 84.48) Previous resistance level of 88 broken. Our short term bias remains positive. Previous resistance, now becomes support at 88. 50 1day EMA is at 86.97. Support is located at 88 and should stem dips to this area. Daily signals are mildly bullish. Our profit targets will be 96.72 and 97.72...
NYSE:PFE broke out at 45.60 and after hitting a high of 58, it then retested support in Oct 2022. It has now broken out and is heading higher.
Sanofi India has a breakout on DAILY TIMEFRAME. The target will be found 6700 to 7700 Can be bought for long term If it closes below 5300 A stop-loss of 5300 can be maintained
Breakout in abbott india at the levels of 18000-18200 stock is above of the 200ema it may test its all time high buy at current levels for the targets above 22000.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for...
NSE:APOLLOHOSP large cap health care stock is touching triangle's resistance for 5th time in this year. With positive earnings and bull market, this breakout can sustain if pharma sector picks momentum again. Key note : Always follow proper risk management to avoid losing capital from false breakouts as this is common. Caution : This is a knowledge sharing...